The upregulated expression of FASN ovarian cancer cell lines and primary cultures increases de novo fatty acid synthesis, cell growth, and cell viability, and enhances chemoresistance to cisplatin [69,70]. The gene discussed is FASN; the disease is ovarian cancer.